rhenium has been researched along with Thrombocytopenia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandurski, T; Derejko, M; Romanowicz, G; Scheffler, J | 1 |
| Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
| Blijham, GH; de Klerk, JM; Han, SH; Stokkel, MP; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
| Blijham, GH; de Klerk, JM; Hoekstra, A; Rutgers, DH; van Dieren, EB; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
| Blijham, GH; de Klerk, JM; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
| Silberstein, EB | 1 |
| Behr, T; Blumenthal, RD; Goldenberg, DM; Haywood, L; Sharkey, RM | 1 |
| de Klerk, JM; Huiskes, AW; van Dijk, A; van Het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
| Spencer, RP | 1 |
| Colnot, DR; Huijgens, PC; Quak, JJ; Roos, JC; Snow, GB; van Dongen, GA; van Kamp, GJ; van Lingen, A; Wilhelm, AJ | 1 |
| Cloos, J; Colnot, DR; de Bree, R; Quak, JJ; Roos, JC; Snow, GB; van Dongen, GA; Wilhelm, AJ | 1 |
1 review(s) available for rhenium and Thrombocytopenia
| Article | Year |
|---|---|
Application of rhenium-188 HEDP in bone metastases therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Leukopenia; Organometallic Compounds; Pain; Palliative Care; Practice Patterns, Physicians'; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Treatment Outcome | 2003 |
5 trial(s) available for rhenium and Thrombocytopenia
| Article | Year |
|---|---|
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer.
Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Thrombocytopenia | 1994 |
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Palliative Care; Radioisotopes; Rhenium; Thrombocytopenia | 1996 |
Dosage and response in radiopharmaceutical therapy of painful osseous metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Male; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia | 1996 |
Can bone marrow scintigraphy predict platelet toxicity after treatment with 186Re-HEDP?
Topics: Aged; Blood Platelets; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Organometallic Compounds; Organotechnetium Compounds; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Thrombocytopenia | 1999 |
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
Topics: Aged; Antibodies, Monoclonal; Antibody Formation; Bone Marrow; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Recombinant Fusion Proteins; Rhenium; Thrombocytopenia | 2000 |
5 other study(ies) available for rhenium and Thrombocytopenia
| Article | Year |
|---|---|
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Middle Aged; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia | 1994 |
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts.
Topics: Aged; Bone Marrow; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Palliative Care; Platelet Count; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Rhenium; Thrombocytopenia | 1996 |
Application of cytokine intervention for improved radio-antibody dose delivery.
Topics: Animals; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoglobulin Fab Fragments; Immunoglobulin G; Interleukin-1; Iodine Radioisotopes; Leukocyte Count; Mice; Mice, Inbred BALB C; Neutropenia; Radioimmunotherapy; Rhenium; Thrombocytopenia; Yttrium Radioisotopes | 1997 |
Quantifying leukocyte and thrombocyte suppression-recovery after Re-186 HEDP for bone metastases.
Topics: Blood Platelets; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Etidronic Acid; Female; Follow-Up Studies; Forecasting; Humans; Leukocyte Count; Leukocytes; Leukopenia; Organometallic Compounds; Platelet Count; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Tin Radioisotopes | 2000 |
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.
Topics: Aged; Algorithms; Antibodies, Monoclonal; Area Under Curve; Bayes Theorem; Bone Marrow; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Predictive Value of Tests; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Recombinant Fusion Proteins; Regression Analysis; Rhenium; Thrombocytopenia | 2001 |